期刊文献+

某院呼吸内科住院患者抗菌药物使用强度合理性分析 被引量:3

Rationality Analysis of Antibiotic Use Intensity for Inpatients in Respiratory Department of a Hospita
下载PDF
导出
摘要 目的:通过统计分析某院呼吸内科住院患者2019年1月份抗菌药物使用强度达标情况,结合该科住院病历点评结果,了解2019年1月份某院呼吸内科抗菌药物使用现状和趋势[1],促进该科临床合理使用抗菌药物,为下一阶段降低该科室抗菌药物使用强度提供依据。方法:通过某院信息管理系统,收集某院呼吸内科2019年1月抗菌药物使用强度等相关数据(如:抗菌药物使用强度、前十名抗菌药物使用品规、使用频度等)进行统计分析,并结合该科平时病历检查结果进行合理性分析和评价。结果:①某院呼吸内科1月份抗菌药物使用强度为每百人/天129.95DDDs,相比目标值100超出29.95,超标较为严重。①2019年1月份某院呼吸内科抗菌药物使用频度前10位排列顺序为:头孢呋辛针0.75 g/支、头孢曲松他唑巴坦针1 g/支、头孢吡肟针0.5 g/支、头孢他啶针0.75 g/支、头孢哌酮舒巴坦针1.5 g/支、头孢呋辛针1.5 g/支、亚胺培南+西司他丁、头孢孟多针0.5 g/支、克林霉素针0.6 g/支、哌拉西林舒巴坦针1.5 g/支。结论:结合抗菌药物使用频度排序和抽查点评结果分析看出,导致抗菌药物使用强度超标的原因主要为:头孢曲松他唑巴坦针、头孢哌酮舒巴坦针、头孢吡肟针单次给药剂量偏高。 Objective:Through statistical analysis to understand the antibacterial drug use intensity of hospitalized patients in respiratory medicine department of a hospital in January 2019,combined with the evaluation results of hospital medical records of the department,to master the current situation and trend of antibacterial drug use in respiratory medicine department of a hospital in January 2019[1],to promote rational clinical use of antibacterial drugs in the department,and to provide basis for reducing the antibacterial drug use intensity in the department in the next stage.Methods:Through the information management system of a certain hospital,relevant data such as antibacterial drug use intensity in January 2019 of respiratory medicine department of a certain hospital(e.g.antibacterial drug use intensity,top ten antibacterial drug use regulations,frequency of use,etc.)were collected for statistical analysis,and rationality analysis and evaluation were conducted in combination with the usual medical record examination results of the department.Results:1.In January,the use intensity of antibacterial drugs in respiratory medicine department of a hospital was 129.95DDDs per 100 people/day,which exceeded the target value of 100 by 29.95 and exceeded the standard seriously.2.in January 2019,the top 10 orders of the use frequency of antibacterial drugs in respiratory medicine department of a hospital are:cefuroxime 0.75 g/branch,ceftriaxone tazobactam 1 g/branch,cefepime 0.5 g/branch,ceftazidime 0.75 g/branch,cefoperazone sulbactam 1.5 g/branch,cefuroxime 1.5 g/branch,imipenem+cilastatin,cefamandole 0.5 g/branch,clindamycin 0.6 g/branch,piperacillin sulbactam 1.5 g/branch.Conclusion:Combined with the ranking of the use frequency of antibacterial drugs and the analysis of random inspection and comment results,it can be seen that the main reason for the over-standard use intensity of antibacterial drugs is that the single dose of ceftriaxone tazobactam needle,cefoperazone sulbactam needle and cefepime needle is too high.
作者 李莉春 Li Lichun(Department of Pharmacy,Huizhou Sixth People's Hospital,Huizhou 516001,Guangdong)
出处 《北方药学》 2020年第4期194-195,共2页 Journal of North Pharmacy
关键词 呼吸内科 抗菌药物 使用强度 Respiratory Medicine Department Antibiotics Use intensity
  • 相关文献

参考文献6

二级参考文献36

  • 1Clinical and Laboratory Standards Institute(CLSI). Performance Standards for Antimicrobial susceptibility testing[S]. 2007. 被引量:1
  • 2Rodriguez-Bano J, Paterson DL. A change in the epidemicology of infections due to exterded spectrum β-lactamase producing organisms[J]. Clin Infect Dis, 2006,42(7) :935-937. 被引量:1
  • 3Paterson DL. The epidemiological profile of infections with multidrug resistant Preudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis ,2006, 43(suppl 2):S43-S48. 被引量:1
  • 4Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa[J].Clin Infect Dis, 2006, 43(suppl 2):S49-S56. 被引量:1
  • 5Zavascki AP, Goldani LZ, Li J, et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review[J].J Anitmicrob Chemother, 2007, 60(6) : 1206-1215. 被引量:1
  • 6Li J, Nation RL, Turnidge JD, et al. Colistin:the re-emerging antibiotic for multidrug-resistant Gram-regative bacterial infections[J]. Lancet Infect Dis, 2006, 6(9) : 589-601. 被引量:1
  • 7Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis, 2006, 43 ( suppl 2) : S95- S99. 被引量:1
  • 8Dellit TH, Owens RC, McGowan JE, et al. Infectious diseases society of america and the society for healtheare epidemiology of america guidelines for developingooinstitutional program to enhance antimicrobial stewardship~J~. Clin Infect Dis, 2007, 44:159-177. 被引量:1
  • 9Carling P,Fung T,Killion A, et al. Favorable impact of a m u hidisciplinary antibiotic management program conducted dur- ing 7 years[J]. Infect Control Hosp Epidemiol, 2003,24 : 699-706. 被引量:1
  • 10Fowler S, Webber A, Cooper BS, et al. Succesdul of feedback to im- prove antibiotic prescribing and reduce Clestridium difciIIe infec- tion:a controlled interrupted time series[J]. J Antimiemb Che- mother, 2007,59 : 990-995. 被引量:1

共引文献384

同被引文献24

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部